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Abstract 
Aim: The resistance of placental blood vessels might be increased in diabetic pregnancies. This 
increased resistance can affect uteroplacental blood flow and influence the oxygen and nutrient 
supply of the fetus and fetal growth. Our aim was to compare the ultrasonographic, 
pathomorphologic data and vasoreactivity of umbilical and placental vessels of gestational diabetic 
newborns with that of normal pregnancy newborns. 
Methods: In this case-control study the placental vascularization of pregnant women was 
determined by 3D power Doppler ultrasound technique. We calculated the vascularization index (VI), 
flow index (FI) and vascularization flow index (VFI). We performed a tissue bath experiment (treatment 
with oxytocin and desmopressin) on umbilical vessels and collected pathomorphologic data 
according to the Royal College of Pathologists’ 2011 protocol. 
Results: The placental vascularization index and the umbilical artery S/D were significantly lower in 
the case group. The mean VI was 6.21% (±2.69 SD) in control versus 3.5% (±2.97 SD) (p<0.05) in GDM. 
The mean value of the umbilical artery S/D was 2.27 (±0.22 SD) and 2.18 (±0.45 SD) (p<0.05) 
respectively. In an isolated tissue bath experiment, oxytocin and desmopressin did not elicit 
significant contraction on umbilical cord vessels. 
Conclusion: Our results suggest that umbilical vessels might have a different receptor pathway 
regulation that can compensate for the rheological changes in the pregnant woman’s blood flow and 
gives opportunity for selective therapy to fetuses more vulnerable to hypoxia. 
(Jakó M, Surányi A, Kaizer L, Domokos D, Bártfai G. The Correlation of Ultrasonographic and 
Pathophysiologic Measurements of Umbilical Vessels in Gestational Diabetes. SEEMEDJ 2017;1(1);40-
49) 
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Introduction 
Gestational diabetes mellitus (GDM) affects 14% 
of pregnancies, or 135,000 women a year in the 
USÄ, although its incidence varies nationwide. 
The mother’s risk for conversion to type 2 
diabetes ranges from 2.6 to 70% over a period 
from 6 weeks to 28 years postpartum (1). There 
are many, noncorresponding data regarding the 
prevalence of GDM in Hungary. In a population-
based screening program, 75 g OGTTs were 
offered to all pregnant women between 24–28 
weeks of gestation and evaluated according to 
WHO criteria. In that study 8.7% of pregnant 
women were diagnosed with GDM, and the risk 
increased linearly with maternal age. Women 
with the highest BMI (≥ 29.2 kg/m2) had 
decreased risk compared to women with a BMI 
of 26.1–29.1 kg/m2 (p<0.05). These results 
suggest that pre-pregnancy BMI and previous 
deliveries elevate the risk of GDM only to a 
certain level, above which the risk decreases (2). 
Postprandial glucose concentrations steadily 
increase as tissue sensitivity to insulin 
decreases. To maintain proper blood glucose 
value along pregnancy, the pancreatic gland of 
the mother increases insulin secretion to 
compensate. Insulin resistance and impaired 
insulin secretion by the pancreas cause the 
development of GDM, especially during the third 
trimester of pregnancy (3). Pregnancy is a 
complex metabolic state that involves dramatic 
alterations in the hormonal milieu, changes in 
adipokines and inflammatory cytokines. There 
are high levels of estrogen, progesterone, 
prolactin, cortisol, human chorionic 
gonadotropin, placental growth hormone, 
human placental lactogen, leptin, TNFα, and 
oxidative stress biomarkers. In addition, 
decreases in adiponectin worsen maternal 
insulin resistance in the second trimester (4). The 
placental and fetal demands for glucose are 
considerable and approach the equivalent of 
~150 grams per day of glucose in the third 
trimester. Glucose transport to the fetus occurs 
in direct proportion to maternal glucose levels, 
and is augmented by a five-fold increase in a 
placental glucose transporter, (GLUT-1) which 
increases transplacental glucose flux (5). 
Fetuses exposed to a high glucose environment 
usually have medical complications after 
delivery, including infant respiratory distress 
syndrome, cardiomyopathy, hypoglycemia, 
hypocalcemia, hypomagnesaemia, 
polycythemia, and hyperviscosity. The 
hyperglycemia and adverse pregnancy 
outcome (HAPO) study, which investigated 
about 25,000 pregnant women in 15 centers, 
found that even in subclinical hyperglycemia, 
higher maternal BMI was associated (odds ratio 
[95% confidence interval] with an increased 
frequency of birthweight >90th percentile (3.52 
[2.48–5.00]) and percentage of body fat >90th 
percentile (3.28 [2.28–4.71]), caesarean section 
(2.23 [1.66–2.99]), and cord C-peptide >90th 
percentile (2.33 [1.58–3.43]) (6). The first line of 
management of women with gestational 
diabetes is medical nutrition therapy and a given 
minimum of exercise. Patients who fail to 
maintain normal glycemic values via diet and 
exercise therapy receive insulin (7). 
As umbilical cord vessels represent a suitable 
model for the study of vascular alterations 
brought about by GDM, the aim of the present 
work was to compare the ultrasonographic 
vascular flow measurements to pathological 
microvascular changes, and also to test the 
vasoreactivity of the vessels. The chosen agents 
were oxytocin, which is present naturally at the 
time of pregnancy and can pass through the 
placenta (8), and vasopressin, an oxytocin 
receptor agonist. Oxytocin and vasopressin are 
both peptide hormones, and oxytocin is widely 
used to promote labor contractions in clinical 
practice. The effects of these peptides are 
mediated via transmembrane receptors. Both 
the oxytocin receptor (OTR) and the V1a 
vasopressin receptor (V1aR) are expressed in 
human myometrium. The expression of OTR is 
significantly higher in gravid uterus while V1aR 
expression is not significantly elevated 
compared to non-gravid uterus (9). Oxytocin 
gene and receptor expression have also been 
shown in human chorion, deciduas and amnion 
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epithelial cells with the onset of labor. The 
structural similarity of the two peptides 
(approximately 80%), as well as the homology of 
the receptors, causes some cross-reactivity 
between peptides and receptors (10).The 
placental presence of V1aR mRNA is known in 
sheep but not in humans. The lack of AVP mRNA 
suggests the fetal origin of the ligand (11). 
Pharmacological studies suggest the existence 
of vascular endothelial AVP/OT receptors that 
mediate a vasodilatory effect. However, the 
nature of the receptor subtype(s) involved in this 
vasodilatory response remains controversial. 
RT-PCR experiments with total RNA extracted 
from a human umbilical vein endothel amplified 
the OT receptor sequence only, but various 
vascular beds display different sensitivities to 
AVP (12). Other studies suggest that the 
vasopressine receptor type 2 is responsible for 
vasodilation via nitrogen-monoxide production 
(13,14). To the best of our knowledge, no 
receptor subtypes have been investigated in 
umbilical arteries, and the fetal production of the 
ligands is a hypothesis. 
We hypothesize that during myometrial 
contraction the above mentioned vascular 
relaxation can maintain fetoplacental circulation. 
The aim of this study was to investigate whether 
the vasodilatory effect of AVP/OT receptor 
pathways is present in fetoplacental circulation. 
We also wanted to investigate whether the 
diabetic vasculopathy and vessel calcification 
affects this vasodilation. 
Materials and Methods 
Ultrasound screening 
We collected samples of umbilical cords from 
the Department of Obstetrics and Gynecology at 
the University of Szeged from October, 2013 
until June, 2014. Focusing on the well-known risk 
factors, a detailed medical history was taken, 
and relying on the results of routine ultrasound 
screening, fetal biometry and anamnesis, we set 
up a case group of gestational diabetic 
pregnancies (GDM fetuses) (n = 5) and compared 
them to a control group (n = 22).  
Gestational diabetes was diagnosed at 
gestational weeks 24-28 as hyperglycemia, first 
detected in pregnancies that met the WHO’s 
guide criteria (15). Each of the patients with 
gestational diabetes was treated with dietary 
restrictions and monitoring. No insulin treated 
patients were included. The control group 
consisted of patients without diabetes or other 
endocrinologic, vascular or pulmonary disease. 
They delivered normal weight, healthy 
newborns. Those who did not fit any of the 
above criteria were excluded from this study. 
Gestational age was determined based on the 
first day of the last menstrual period and on 
ultrasound biometry (crown-rump length [CRL] 
and biparietal diameter [BPD]) at the 10th week 
of pregnancy. All patients were scanned in a 
semirecumbent position. The factorial default 
setting "Obstetrics/2-3 trimester" was used in 2-
D mode. The examination was followed by a 
fetal biometry to assess BPD, head 
circumference (HC), abdominal circumference 
(AC) and femur length (FL). Fetal weight was 
calculated by the formula B of Hadlock (16). A 
conventional color Doppler study of umbilical 
arteries was also performed and the systolic 
velocity/diastolic velocity(S/D) ratio, the 
resistance index (RI) and pulsatility index (PI) 
were read from the ultrasound report display. 
The images used for the determination of 
placental volume and three-dimensional power 
Doppler (3DPD) indices were obtained at the 
time of the visit. All 3-D scans and the 2-D 
ultrasound measurements were performed. 
Voluson 730 Expert ultrasound machines 
equipped with a multifrequency probe (2-5 MHz) 
were used to acquire all images (GE Medical 
Systems, Kretztechnik GmbH&Co OHG, Austria). 
Each sample was examined using a 3-D 
rendering mode, in which the color and gray 
value information was processed and combined 
to produce 3-D images (mode cent; smooth: 4/5; 
FRQ: low; quality: 16; density: 6; enhance: 16; 
balance: 150; filter: 2; actual power: 2 dB; pulse 
repetition frequency: 0.9). A power Doppler 
window (pulse repetition frequency at 900 Hz 
and wall filter of 50 Hz) was placed over the 
placenta mapping the vascular tree from the 
basal to chorionic plates. We used fast low 
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resolution acquisition to avoid any kind of 
artifact. The 3-D static volume box was placed 
over the highest villous vascular density zone at 
umbilical cord insertion (17-19). During gestation 
we recorded one sample from each patient. The 
stored volumes were further analyzed using the 
Virtual Organ Computer-aided Analysis (VOCAL) 
program pertaining to the computer software 4D 
View (GE Medical Systems, Austria, version 10.4) 
by an expert in 3-D analysis (18).The power 
Doppler technique shows high sensitivity, 
because it is based on amplitude instead of 
mean frequencies to depict the vascular tree 
(19). Moreover, the color mapping is 
independent from the angle of insonation and 
does not show “aliasing”. The placental vascular 
indices from sonobiopsy are a valid alternative 
for evaluation of the placental vascular tree 
when visualization of the entire placenta is not 
feasible.  Based on the ultrasonographic 
technique vascularization index (VI, the 
perfusion of the tissue, the percentage of blood 
flowing through), the flow index (FI, the amount 
of red blood cells flowing through a given area 
in a given time) and their combination, the 
vascularization flow index (VFI) can be 
determined (20). The spherical sample volume 
was consistently 28ml. The VOCAL program 
calculated automatically gray and color scale 
values in a histogram from the acquired 
spherical sample volume in each case (18-19). 
The delivery mode and duration with gestational 
age were recorded in the delivery room along 
with the body weight and body length of the 
newborn, of which Rhohner's ponderal index 
could be calculated with a normal value 
between 2.2 and 2.9. For statistical reasons, the 
gender and 1-5 minute Apgar-scores were also 
registered. 
Tissue Bath Study 
At the placental insertion two 10 cm long 
segments of the umbilical cord were removed 
immediately and the one proximal to the 
placenta was stored at 4C, in pH 7.4 Krebs-
Henseleit solution (118 mM NaCl; 4.7 mM KCl; 1.2 
mM KH2PO4; 1.2 mM MgSO4.7H2O; 2.5 mM 
CaCl2 2H2O; 25 mM NaHCO3, 11.7 mM dextrose). 
The samples were processed and stored in an 
ice-lined stainless steel thermos, and the 
solution was freshly prepared on a weekly basis 
and stored in a refrigerator until used. The 
vessels were dissected from Wharton’s jelly 
within 24 hours to maintain their reactivity 
(11).The arteries were cut into two 3-5 mm long 
rings, and 4 similar rings were prepared from the 
vein. They were suspended on stainless steel 
hooks and placed in a tissue bath containing a 
Krebs-Henseleit solution at 37°C, exposed to 2g 
initial tension and bubbled with carbogen (95% 
O2, 5% CO2). During the sixty-minute 
equilibration time we washed the system 
throughout with fresh solution every 15 minutes 
and let the spontaneous basal tone of the 
vessels to develop. Oxytocin and desmopressin 
were added to the vessels in the concentration 
range of 10-9-1x10-5M and 10-11-10-7M, 
respectively. The change in the vascular tone 
was detected by isometric sensors and 
recorded and analyzed by ISOSYS S.P.E.L. 
advanced computer software (Experimetria Ltd, 
Budapest, Hungary). The results are interpreted 
as the percentage of the basal, spontaneous 
vascular tone represented as 100% in value. The 
functionality of the vessel rings was tested with 
serotonin, which caused vasoconstriction, 
proving the viability of the vessels. 
Pathological Examination 
The placenta, along with the other segment of 
the cord, was stored in formalin for the 
morphological and histological examinations. 
The macroscopic evaluation of the samples 
followed the protocol published in 2011 by the 
Royal Society of Pathologists (22). From the 
length of the sample and the number of 360 
turns by the vessels, we calculated the umbilical 
coiling index (UCI), with the standard normal 
value of one. In addition, with two scalpels fixed 
in the distance of two cm, three sections of the 
cord were cut. We stained their ends with ink 
and made prints on a millimeter paper, allowing 
them to be pushed to the paper by their natural 
weight. All the samples were handled by the 
same person. The area of the cross-sectional 
surface was measured using Image J 1.47v (2013) 
computer software on 3x6 prints in each case. 
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For the preparation and evaluation of the 
histological sections of the samples, we used 
the remaining cord and placental tissue. These 
data fundamentally determined the subsequent 
evaluation of the results. Two-way ANOVA 
statistical analysis was performed via Prism 6 (c 
1992-2012 GraphPad Software Inc.). 
Results 
All together 27 placentas and cords (22 control 
and 5 GDM) were examined. The mean age of 
the pregnant women in the control group was 
32.09 (±5.66 SD) versus 34.20 (±4.97 SD) in the 
GDM group. The number of previous gestations 
was 1.46 in the control and 2.8 in the GDM group. 
We recorded two previous intrauterine growth 
restricted newborns in the diabetic group, and 
one macrosomic newborn in the control group. 
Pregnancy has long been known to be 
diabetogenic in the sense of the progressive 
metabolic changes. Proportional regression 
analysis revealed that the relative risk of 
developing non-insulin-dependent diabetes 
mellitus postpartum was 1.95 (95% CI, 1.63-2.33) 
for each 4.5 kg of weight gained during follow-
up (23). 
In the control group, medications taken during 
pregnancy were either one of the available over-
the-counter pregnancy multivitamins or none at 
all. In the GDM group, methyldopa, magnesium, 
vitamin B6, verapamil-hydrochloride, calcium-
dobezilat and multivitamins were take none 
month prior to giving birth. The clinical data of 
the pregnant women and their newborns are 
summarized in Table 1. 
All three vessels were present in each case 
along the entire length of the three to seven 
days old formalin-fixed samples. The 
pathomorphological data are shown in Table 2. 
The coiling of the cords is typically 
counterclockwise, twisted to the left, but 
twisting to the right occurred in 4 cases too; in 
the healthy control group (n = 3) and in the GDM 
group (n = 1). The UCI was calculated as the 
number of full turns made by the vessels within 
five centimeters. Perivascular hematoma and 
one hemangioma cavernosum were observed in 
the control, while two cases of multiple false 
knots, a slight funisitis and edematous cord were 
found in the GDM group. True knots, abnormal 
vascular division, stenosis, striction, meconium 
staining, maceration, thrombosis, calcification 
around the vessels, or other differences, 
discoloration, or odor were not observed. The 
cross-sectional surface area of the formalin-
fixed tissue was compared to the measurements 
made on the ultrasonographic images. The 
cross-sectional surface area of the GDM fetuses’ 
umbilical cords is roughly 65% of control cords 
measured in utero, and 76% after formalin 
fixation. The mean cord cross-sectional areas 
measured by 2D ultrasound were 344.00 mm2 
(±0.46 SD) in the control group and 224.50 mm2 
(±0.74 SD) in the diabetic group (p<0.05). After 
formalin fixation for three to seven days the 
cross-sectional areas were 124.00mm2 (±35.47 
SD) and 93.75mm2 (±9.86 SD) respectively 
(p<0.05). 
Measured with the ultrasonographic VOCAL 
technique, we found that the mean FI was 
34.45% (±4.59 SD) in the control group and 29.80% 
(±3.68 SD) in the GDM group (ns); the mean VI 
was 6.21% (±2.69 SD) and 3.5% (±2.97 SD) (p<0.05), 
and the mean VFI was 2.31% (±1.23SD) and 0.95% 
(±1.20 SD) (ns) respectively. The mean value of 
the umbilical artery S/D was 2.27 (±0.22 SD) in 
controls and 2.18 (±0.45 SD) (p<0.05) in diabetic 
pregnancies.  
Oxytocin did not elicit significant change in the 
vascular tone in the arteries and the veins, and 
the responsiveness of the vessels was not 
different significantly in the two groups (Figure 
1). Desmopressin was also added to the vessels 
in logarithmic noncumulative concentrations (24) 
as shown in Figure 2, but there was again no 
response. 
Discussion 
In our study, umbilical 3D ultrasound 
examination showed that, compared to their 
gestational age, GDM fetuses have the normal 
S/D velocity curve. The VI is lower than in 
normal pregnancies because the development 
of blood vessels is not proportional to the 
growth of the placenta. In addition, they are 
damaged by the high serum glucose level. The 
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increased entry of glucose into vascular smooth 
muscle cells via GLUT1 transporter mediated by 
IL1β activates the pentose phosphate pathway, 
thus permitting some of the excess glucose to 
be metabolized via this route. This in turn led to 
an over activation NADPH oxidase, resulting in 
increased generation of free radicals and the 
subsequent downstream proinflammatory 
signaling. Free radicals, inflammation and 
oxidative stress lead to atherosclerosis (25). 
The uteroplacental circulation can be detected 
by the flowmetry of the umbilical and uterine 
arteries. The wave and shape of the flow, both in 
umbilical and uterine arteries, depends on the 
Table 1. Clinical and biometric data of the pregnants and newborns. 
 
Control (n=22) GDM (n=5)  
Mean SD SEM Mean SD SEM p 
BMI before pregnancy 21.68 3.18 1.20 24.42 5.58 2.79 0.3968 
BMI after pregnancy 25.85 1.85 0.58 30.83 4.44 1.98 0.0425* 
previous pregnancies 1.46 1.97 0.59 2.80 0.84 0.37 0.0226* 
systolic blood pressure (Hgmm) 123.20 25.86 7.80 124.00 19.49 8.72 0.9185 
diastolic blood pressure (Hgmm) 78.00 10.63 3.21 83.00 13.04 5.83 0.4395 
gestational age (weeks) 39.20 1.23 0.39 38.22 2.54 0.85 0.2812 
1 minute Apgar 9.46 0.52 0.16 8.20 1.1 0.49 0.0213* 
5 minute Apgar 10.00 0.00 0.00 9.00 1.23 0.55 0.1419 
Rhohner’s ponderal index 2.69 0.25 0.08 2.85 0.35 0.16 0.1867 
BMI of newborn 13.16 0.96 0.32 14.10 1.99 0.89 0.3518 
weight (g) 3221 266.1 94.08 3627 363.5 148.40 0.0411* 
AC (mm) 290.5 34.65 24.50 383.80 29.26 14.63 0.6981 
HC (mm) 303.50 9.19 6.50 318.50 16.30 8.15 0.1533 
AC/HC 1.04 0.07 0.04 1.28 0.08 0.04 0.1238 
BPD (mm) 88.00 4.69 2.34 92.50 3.78 2.18 0.1750 
FOD (mm) 109.50 5.92 3.42 115.00 9.01 4.50 0.3458 
FL (mm) 65.50 6.61 3.30 73.00 4.00 2.31 0.0832 
FL/BPD 0.74 0.07 0.04 0.79 0.03 0.02 0.0980 
BMI before pregnancy 21.68 3.18 1.20 24.42 5.58 2.79 0.3968 
*p<0.05 
BMI= body mass index, AC= abdominal circumference, HC= head circumference, BPD= biparietal diameter, FOD= frontooccipital 
diameter, FL= femur length. 
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resistance in placental circulation. In diabetes, 
the increased blood flow resistance of the 
umbilical artery is just a late pathognomic sign of 
ischemic vascular changes in the placenta 
related to a direct ischemic effect on 
vascularization. These ischemic-hypoxic 
alterations can be seen in histopathological 
samples as syncytial nodes, hypervascularized 
villi and excessive interstitial calcification 
(26).We would like to emphasize the importance 
of the placental-umbilical cord unit in pathologic 
pregnancies. 
According to our results, the umbilical cord in 
the case of a gestational diabetic patient can be 
described as a thin cord with normal length, 
hypercoiled or normally coiled rope-like vessels. 
The incidence of multiple false knots is higher, 
and they rather tend to have a marginal 
placental insertion.  
Table 2. The pathomorphological and histopathologic data of the samples. 
 
Control (n=22) GDM (n=5)  
Mean SD SEM Mean SD SEM p 
cord cross-sectional area (mm2) 124.00 35.47 11.22 93.75 9.86 4.41 0.0027* 
cord length (cm) 58.00 9.15 2.89 59.60 7.13 3.19 0.6400 
placental weight (g) 463.80 56.77 17.12 535.40 78.53 35.12 0.1083 
fetal weight/placental weight 7.38 0.76 0.23 6.29 0.56 0.25 0.0134* 
placenta thickness (mm) 27.73 4.10 1.24 28.00 4.47 2.00 0.8880 
placenta longest diameter (mm) 160.90 13.75 4.15 164.00 5.48 2.45 0.1778 
placenta shortest diameter (mm) 139.10 17.00 5.13 158.00 8.37 3.74 0.0071 
umbilical coiling index (UCI) 1.43 0.77 0.25 2.00 1.00 0.45 0.0891 
*p<0.05 
Figure 1. Maximum change in vascular tone after oxytocin 
dosage. 
 
Although the mean value for the case group is lower, the 
difference was not significant; p=0.208 in case of the arteries 
and p=0.396 in case of the veins. CTRL= control group, GDM= 
gestational diabetic group. 
Figure 2. Vascular tone after oxytocin and desmopressin 
dosage 
 
 
We considered the spontaneously developing basal tone as 
100%.24 
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On the placental perfusion model, introducing 
vasopressin to the maternal side (30pg/ml-60 
000pg/ml) and increasing the dosage until the 
vasopressin reaches its maximum concentration 
on the fetal side, they received 3110 pg/ml as 
the maximal agent transported through the 
placenta. This concentration is equivalent with 
5.74x10-9M, while our highest concentration was 
10-7M. This suggests that treating pregnant 
women with vasopressin would not influence 
the fetoplacental circulation. Vasopressin or 
oxytocin concentration still can be increased in 
vivo by fetal production (27). 
As described by Holcberg G., et.al (2002) 
oxytocin does have a vasoactive effect on 
meconium impregnated placentas, but no effect 
on normal placentas. Maternal oxytocin can pass 
through the placenta and reach the fetal brain, 
and induce the hyperpolarization of GABAergic 
neurons in the fetal hippocampus and neocortex 
during delivery. Reduction of GABA-mediated 
excitation induced by oxytocin has been 
demonstrated and completely eliminated by 
Atosiban. Since hypoxic brain damage is the 
leading cause of fetal death, the important 
conclusion is that oxytocin has an inhibitory 
cortical and hippocampal neuronal effect by 
which it reduces fetal brain oxygen and nutrient 
requirements, and therefore it is less sensitive to 
hypoxia (4). Therefore we assume that in cases 
of placentas without meconium impregnation, 
oxytocin does not bind to the receptors to elicit 
vasoconstriction in the placenta, and it can pass 
to the umbilical cord, where there is no active 
receptor. Thus, it can exert a greater 
hyperpolarization in the fetal brain. In term 
pregnancies during delivery, if there is an acute 
hypoxia, the oxytocin produced by the mother 
can protect the fetal brain. In contrast, it seems 
that in cases of the presence of meconium for 
several hours, it is important to note the increase 
of vascular tone in the placenta. 
The macroscopic evaluation of the formalin 
fixed tissues showed that the volume had 
reduced, but the ratios between the control and 
case groups remained the same, so these data 
correlated with the clinical measurements. In 
cases of diabetic pregnancies, we found an 
increased umbilical coiling index (number of 
360° turns within 5cm long segment at the 
placental end). The clinical aspect of the coiling 
pattern and coiling index is that a thin and 
hypocoiled cord is more vulnerable to 
strangulation, striction and other mechanical 
events. The thin cord that is not well- protected 
by Wharton’s jelly is prone to striction and 
mechanical injuries too. There was no significant 
difference in the case of birth weight and 
placental weight either, but we did find 
significant difference in their ratios. The shortest 
diameter of the GDM placentas was significantly 
longer than the control ones, while there was no 
significant difference in the longer diameter or 
thickness measured at the cord insertion point. 
Therefore, we might observe the diabetic 
patients’ placentas as more round and less oval 
shaped, heavier, and exhibiting a pale 
calcification. 
We suppose that umbilical vessels have a 
unique receptor profile to regulate vascular tone 
though these vessels may injure easily because 
of mechanical insult. Regarding the importance 
of the umbilical vascular tone in fetal 
development, the investigation of the exact 
biochemical mechanisms could be crucial in the 
prevention of any developmental disturbances 
since the onset of gestational diabetes is within 
the time of pregnancy, resulting in a decreased 
possibility of awareness of the illness by the 
pregnant woman. By taking into consideration all 
the receptor changes of fetoplacental 
vascularization, we may be able to protect the 
fetus from an adverse outcome by specific 
treatment.  
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